Use of Circulating and Cellular miRNAs Expression in Forensic Sciences

1. Hanson EK, Lubenow H, Ballantyne J. Identification of forensically relevant body fluids using a panel of differentially expressed microRNAs. Anal Biochem. 2009;387:303-314.10.1016/j.ab.2009.01.03719454234Search in Google Scholar

2. Verduijn R. Recent Developments in Forensic Biology. BSc Biol. 2010.Search in Google Scholar

3. Petersen CH, Hjort BB, Tvedebrink T, Kielpinski LJ, Vinther J, Morling N. Body fluid identification of blood, saliva and semen using second generation sequencing of micro-RNA. Forensic Sci Int Genet Suppl Ser. 2013;4:e204-e205.10.1016/j.fsigss.2013.10.105Open DOISearch in Google Scholar

4. Wang Z, Zhang J, Luo H, Ye Y, Yan J, Hou Y. Screening and confirmation of microRNA markers for forensic body fluid identification. Forensic Sci Int Genet. 2013;7:116-123.10.1016/j.fsigen.2012.07.00622909992Open DOISearch in Google Scholar

5. Meng L, Chen L, Li Z, Wu Z-X, Shan G. Roles of microRNAs in the Caenorhabditis elegans nervous system. J Genet Genomics. 2013;40:445-452.10.1016/j.jgg.2013.07.00224053946Open DOISearch in Google Scholar

6. Zubakov D, Boersma AWM, Choi Y, Van Kuijk PF, Wiemer EC, Kayser M. MicroRNA markers for forensic body fluid identification obtained from microarray screening and quantitative RT-PCR confirmation. Int J Legal Med. 2010;124:217-226.10.1007/s00414-009-0402-3285501520145944Search in Google Scholar

7. Wang Z, Luo H, Pan X, Liao M, Hou Y. A model for data analysis of microRNA expression in forensic body fluid identification. Forensic Sci Int Genet. 2012;6:419-423.10.1016/j.fsigen.2011.08.00821903498Open DOISearch in Google Scholar

8. Meng S, Cao JT, Zhang B, Zhou Q, Shen CX, Wang CQ. Downregulation of microRNA-126 in endothelial progenitor cells from diabetes patients, impairs their functional properties, via target gene Spred-1. J Mol Cell Cardiol. 2012;53:64-72.10.1016/j.yjmcc.2012.04.00322525256Search in Google Scholar

9. Guo HQ, Huang GL, Guo CC, Pu XX, Lin TY. Diagnostic and prognostic value of circulating miR-221 for extranodal natural killer/T-cell lymphoma. Dis Markers. 2010;29:251-258.10.1155/2010/474692Open DOISearch in Google Scholar

10. Deng H, Guo Y, Song H, et al. MicroRNA-195 and microRNA-378 mediate tumor growth suppression by epigenetical regulation in gastric cancer. Gene. 2013;518:351-359.10.1016/j.gene.2012.12.10323333942Search in Google Scholar

11. Uhlich RM, Konie JA, Davis JW, et al. Novel microRNA correlations in the severely injured. Surgery. 2014;156:834-840.10.1016/j.surg.2014.06.01725239329Search in Google Scholar

12. Liu T, Cheng W, Gao Y, Wang H, Liu Z. Microarray analysis of microRNA expression patterns in the semen of infertile men with semen abnormalities. Mol Med Rep. 2012;6:535-542.10.3892/mmr.2012.96722735917Open DOISearch in Google Scholar

13. Chen W, Harbeck MC, Zhang W, Jacobson JR. MicroRNA regulation of integrins. Transl Res. 2013;162:133-143.10.1016/j.trsl.2013.06.008382555423859989Search in Google Scholar

14. Abdelmohsen K, Srikantan S, Kang MJ, Gorospe M. Regulation of senescence by microRNA biogenesis factors. Ageing Res Rev. 2012;11:491-500.10.1016/j.arr.2012.01.003334899522306790Open DOISearch in Google Scholar

15. Westholm JO, Lai EC. Mirtrons: microRNA biogenesis via splicing. Biochimie. 2011;93:1897-1904.10.1016/j.biochi.2011.06.017318518921712066Open DOISearch in Google Scholar

16. Von Brandenstein M, Richter C, Fries JWU. MicroRNAs: Small but amazing, and their association with endothelin. Life Sci. 2012;91:475-489.10.1016/j.lfs.2012.06.02522771694Open DOISearch in Google Scholar

17. Yi R, Qin Y, Macara IG, Cullen BR. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev. 2003;17:3011-3016.10.1101/gad.115880330525214681208Search in Google Scholar

18. Cheng G. Circulating miRNAs: roles in cancer diagnosis, prognosis and therapy. Adv Drug Deliv Rev. 2015;81:75-93.10.1016/j.addr.2014.09.00125220354Search in Google Scholar

19. Andersen HH, Duroux M, Gazerani P. MicroRNAs as modulators and biomarkers of inflammatory and neuropathic pain conditions. Neurobiol Dis. 2014;71:159-168.10.1016/j.nbd.2014.08.00325119878Search in Google Scholar

20. Weilner S, Schraml E, Redl H, Grillari-Voglauer R, Grillari J. Secretion of microvesicular miRNAs in cellular and organismal aging. Exp Gerontol. 2013;48:626-633.10.1016/j.exger.2012.11.017369556623283304Open DOISearch in Google Scholar

21. Rana S, Malinowska K, Zöller M. Exosomal tumor microRNA modulates premetastatic organ cells. Neoplasia. 2013;15:281-295.10.1593/neo.122010359315123479506Open DOISearch in Google Scholar

22. Dumache R, Rogobete AF, Bedreag OH, et al. Use of miRNAs as biomarkers in sepsis. Anal Cell Pathol (Amst). 2015;2015:186716.10.1155/2015/186716449937526221578Search in Google Scholar

23. Weber J, Baxter DH, Zhang S, et al. The MicroRNA Spectrum in 12 Body Fluids. Clin Chem. 2010;56:1733-1741.10.1373/clinchem.2010.147405484627620847327Open DOISearch in Google Scholar

24. Hanson E, Lubenow H, Ballantyne J. Identification of forensically relevant body fluids using a panel of differentially expressed microRNAs. Forensic Sci Int Genet Suppl Ser. 2009;2:503-504.10.1016/j.fsigss.2009.08.184Open DOISearch in Google Scholar

25. Williams G, Uchimoto ML, Coult N, World D, Beasley E, Avenell P. Characterisation of body fluid specific microRNA markers by capillary electrophoresis. Forensic Sci Int Genet Suppl Ser. 2013;4:e274-e275.10.1016/j.fsigss.2013.10.140Open DOISearch in Google Scholar

26. Kuner R, Brase JC, Sültmann H, Wuttig D: microRNA biomarkers in body fluids of prostate cancer patients. Methods. 2013;59:132-137.10.1016/j.ymeth.2012.05.00422652624Search in Google Scholar

27. Gilad S, Meiri E, Yogev Y, et al. Serum microRNAs are promising novel biomarkers. PLoS One. 2008;3:1-7.10.1371/journal.pone.0003148251978918773077Search in Google Scholar

28. Roth C, Rack B, Müller V, Janni W, Pantel K, Schwarzenbach H. Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer. Breast Cancer Res. 2010;12:R90.10.1186/bcr2766304642921047409Search in Google Scholar

29. Guo Z, Maki M, Ding R, Yang Y, Zhang B, Xiong L. Genome-wide survey of tissue-specific microRNA and transcription factor regulatory networks in 12 tissues. Sci Rep. 2014;4.10.1038/srep05150538149024889152Search in Google Scholar

30. Sood P, Krek A, Zavolan M, Macino G, Rajewsky N. Cell-type-specific signatures of microRNAs on target mRNA expression. Proc Natl Acad Sci USA. 2006;103:2746-2751.10.1073/pnas.0511045103141382016477010Search in Google Scholar

31. Bloomston M, WL F, Petrocca F, et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA. 2007;297:1901-1908.10.1001/jama.297.17.190117473300Search in Google Scholar

32. Tsai HL, Yang IP, Huang CW, et al. Clinical significance of microRNA-148a in patients with early relapse of stage II stage and III colorectal cancer after curative resection. Transl Res. 2013;162:258-268.10.1016/j.trsl.2013.07.00923933284Search in Google Scholar

33. Harraz MM, Dawson TM, Dawson VL. MicroRNAs in Parkinson’s disease. J Chem Neuroanat. 2011;42:127-130.10.1016/j.jchemneu.2011.01.005316381321295133Open DOISearch in Google Scholar

34. Papurica M, Rogobete AF, Sandesc D, et al. Advances in Biomarkers in Critical Ill Polytrauma Patients. Clin Lab. 2016;62:977-986.10.7754/Clin.Lab.2015.15110327468558Search in Google Scholar

35. Jones K, Nourse JP, Keane C, Bhatnagar A, Gandhi MK. Plasma microRNA are disease response biomarkers in classical hodgkin lymphoma. Clinical Cancer Research. 2014;20:253-264.10.1158/1078-0432.CCR-13-102424222179Open DOISearch in Google Scholar

36. Yang X, Salminen WF, Shi Q, et al. Potential of extracellular microRNAs as biomarkers of acetaminophen toxicity in children. Toxicol Appl Pharmacol. 2015;284:180-187.10.1016/j.taap.2015.02.013455862225708609Search in Google Scholar

37. Wang F, Li C, Liu W, Jin Y. Effect of exposure to volatile organic compounds (VOCs) on airway inflammatory response in mice. J Toxicol Sci. 2012;37:739-748.10.2131/jts.37.73922863854Search in Google Scholar

38. Cao Y, Yu SL, Wang Y, Guo GY, Ding Q, An RH. MicroRNA-dependent regulation of PTEN after arsenic trioxide treatment in bladder cancer cell line T24. Tumor Biol. 2011;32:179-188.10.1007/s13277-010-0111-z20857258Open DOISearch in Google Scholar

39. Bollati V, Marinelli B, Apostoli P, et al. Exposure to metal-rich particulate matter modifies the expression of candidate MicroRNAs in peripheral blood leukocytes. Environ Health Perspect. 2010;118:763-768.10.1289/ehp.0901300289885120061215Search in Google Scholar

40. Avissar-Whiting M, Veiga KR, et al. Bisphenol A exposure leads to specific microRNA alterations in placental cells. Reprod Toxicol. 2010;29:401-406.10.1016/j.reprotox.2010.04.004289687520417706Open DOISearch in Google Scholar

41. Singh NP, Singh UP, Guan H, Nagarkatti P, Nagarkatti M. Prenatal Exposure to TCDD Triggers Significant Modulation of microRNA Expression Profile in the Thymus That Affects Consequent Gene Expression. PLoS One. 2012;7:e45054.10.1371/journal.pone.0045054344320823024791Search in Google Scholar

42. Liu R, Zhang C, Hu Z, et al. A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. Eur J Cancer. 2011;47:784-791.10.1016/j.ejca.2010.10.02521112772Open DOISearch in Google Scholar

43. Zhang X, Cui L, Ye G, et al. Gastric juice microRNA-421 is a new biomarker for screening gastric cancer. Tumor Biol. 2012;33:2349-2355.10.1007/s13277-012-0497-x22926798Search in Google Scholar

44. Song MY, Pan KF, Su HJ, et al. Identification of serum microRNAs as novel non-invasive biomarkers for early detection of gastric cancer. PLoS One. 2012;7:1-9.10.1371/journal.pone.0033608330385622432036Search in Google Scholar

45. Huang Z, Huang D, Ni S, Peng Z, Sheng W, Du X. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer. 2010;127:118-126.10.1002/ijc.2500719876917Open DOISearch in Google Scholar

46. Zhu C, Tsao M. Prognostic markers in lung cancer: is it ready for prime time? Transl Lung Cancer Res. 2014;3:149-158.Search in Google Scholar

47. Wang P, Yang D, Zhang H, et al. Early Detection of Lung Cancer in Serum by a Panel of MicroRNA Biomarkers. Clin Lung Cancer. 2014;16:313-319. e110.1016/j.cllc.2014.12.00625639977Open DOISearch in Google Scholar

48. Rehbein G, Schmidt B, Fleischhacker M. Extracellular microRNAs in bronchoalveolar lavage samples from patients with lung diseases as predictors for lung cancer. Clin Chim Acta. 2015;450:78-82.10.1016/j.cca.2015.07.02726232753Search in Google Scholar

49. Powrózek T, Krawczyk P, Kowalski DM, Winiarczyk K, Olszyna-Serementa M, Milanowski J. Plasma circulating microRNA-944 and microRNA-3662 as potential histologic type-specific early lung cancer biomarkers. Transl Res. 2015;166:315-323.10.1016/j.trsl.2015.05.00926079400Search in Google Scholar

50. Zhou J, Yu L, Gao X, et al. Plasma MicroRNA Panel to Diagnose Hepatitis B Virus–Related Hepatocellular Carcinoma. J Clin Oncol. 2011;29:4781-4788.10.1200/JCO.2011.38.269722105822Open DOISearch in Google Scholar

51. Vincent L, Vang D, Nguyen J, et al. Mast cell activation contributes to sickle cell pathobiology and pain in mice. Blood. 2013;122:1853-1862.10.1182/blood-2013-04-498105377249523775718Search in Google Scholar

52. Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA. 2008;105:10513-10518.10.1073/pnas.0804549105249247218663219Search in Google Scholar

53. Redova M, Sana J, Slaby O. Circulating miRNAs as new blood-based biomarkers for solid cancers. Futur Oncol. 2013;9:387-402.10.2217/fon.12.19223469974Search in Google Scholar

54. Lavie L, Lavie P. Molecular mechanisms of cardiovascular disease in OSAHS: The oxidative stress link. Eur Respir J. 2009;33:1467-1484.10.1183/09031936.0008660819483049Open DOISearch in Google Scholar

55. Fichtlscherer S, De Rosa S, Fox H, et al. Circulating microRNAs in patients with coronary artery disease. Circ Res. 2010;107:677-684.10.1161/CIRCRESAHA.109.21556620595655Search in Google Scholar

56. Weber M, Baker MB, Patel RS, Quyyumi AA, Bao G, Searles CD. MicroRNA Expression Profile in CAD Patients and the Impact of ACEI/ARB. Card Res Pract. 2011;2011:532915.10.4061/2011/532915313798721785714Search in Google Scholar

57. Cheng Y, Tan N, Yang J, et al. A translational study of circulating cell-free microRNA-1 in acute myocardial infarction. Clin Sci (Lond). 2010;119:87-95.10.1042/CS20090645359381520218970Search in Google Scholar

58. Ai J, Zhang R, Li Y, et al. Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochem Biophys Res Commun. 2010;391:73-77.10.1016/j.bbrc.2009.11.00519896465Search in Google Scholar

59. Olivieri F, Antonicelli R, Lorenzi M, et al. Diagnostic potential of circulating miR-499-5p in elderly patients with acute non ST-elevation myocardial infarction. Int J Cardiol. 2013;167:531-536.10.1016/j.ijcard.2012.01.07522330002Search in Google Scholar

60. Cogswell JP, Ward J, Taylor IA, et al. Identification of miRNA changes in Alzheimer’s disease brain and CSF yields putative biomarkers and insights into disease pathways. J Alzheimers Dis. 2008;14:27-41.10.3233/JAD-2008-14103Open DOISearch in Google Scholar

61. Karolina DS, Armugam A, Tavintharan S, et al. MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus. PLoS One. 2011;6.10.1371/annotation/698b7123-174f-4a09-95c9-fd6f5017d622Search in Google Scholar

62. Bedreag OH, Sandesc D, Chiriac SD, et al. The Use of Circulating miRNAs as Biomarkers for Oxidative Stress in Critically Ill Polytrauma Patients. Clin Lab. 2016;62:263-274.10.7754/Clin.Lab.2015.150740Search in Google Scholar

63. Sun T, Chen X, Liu Z, et al. Expression profiling of MicroRNAs in hippocampus of rats following traumatic brain injury. J Huazhong Univ Sci Technol Medical Sci. 2014;34:548-553.10.1007/s11596-014-1313-125135725Open DOISearch in Google Scholar

64. Butcher N, Balogh ZJ. The definition of polytrauma: the need for international consensus. Injury. 2009;40:S12-S22.10.1016/j.injury.2009.10.03219895948Search in Google Scholar

65. Liu NK, Wang XF, Lu B, Xu XM. Altered microRNA expression following traumatic spinal cord injury. Exp Neurol. 2009;219:424-429.10.1016/j.expneurol.2009.06.015281050819576215Search in Google Scholar

66. Huang C, Xiao X, Chintagari NR, Breshears M, Wang Y, Liu L. MicroRNA and mRNA expression profiling in rat acute respiratory distress syndrome. BMC Med Genomics. 2014;7:1-15.10.1186/1755-8794-7-46412853625070658Open DOISearch in Google Scholar

67. Ndegwa LK, Katz MA, McCormick K, et al. Surveillance for respiratory health care-associated infections among inpatients in 3 Kenyan hospitals. Am J Infect Control. 2014;42:985-990.10.1016/j.ajic.2014.05.02225179331Search in Google Scholar

68. Wang J, Yu M, Yu G, et al. Serum miR-146a and miR-223 as potential new biomarkers for sepsis. Biochem Biophys Res Commun. 2010;394:184-188.10.1016/j.bbrc.2010.02.14520188071Search in Google Scholar

69. Vasilescu C, Rossi S, Shimizu M, et al. MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis. PLoS One. 2009;4:e7404.10.1371/journal.pone.0007405275662719823581Search in Google Scholar

70. Schmidt WM, Spiel AO, Jilma B, Wolzt M, Müller M. In vivo profile of the human leukocyte microRNA response to endotoxemia. Biochem Biophys Res Commun. 2009;380:437-441.10.1016/j.bbrc.2008.12.19019284987Search in Google Scholar